New microbicides enter trials in United States.
Two potential candidates in the microbicide research pipeline are set to be examined in clinical trials, with research to focus on the safety and acceptability in healthy women and women infected with HIV.
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D012747:Sexual Partners; D014481:United States
D000890:Anti-Infective Agents